Nosocomial infections in patients with cancer

The Lancet Oncology

Volumn 10, Issue 6, 2009, Pages 589-597

  Kamboj, Mini ^a   Sepkowitz, Kent A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ANTIMYCOBACTERIAL AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CHICKENPOX VACCINE; CYCLOPHOSPHAMIDE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; METICILLIN; MONOCLONAL ANTIBODY; OSELTAMIVIR; PALIVIZUMAB; PENTOSTATIN; PURINE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; SIALIDASE INHIBITOR; STEROID; TEMOZOLOMIDE; VANCOMYCIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIBIOTIC RESISTANCE; CATHETER INFECTION; CHICKENPOX; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG ERUPTION; DRUG MEGADOSE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LEGIONELLA; LEUKEMIA; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIOSIS; NONHUMAN; PARAINFLUENZA VIRUS; PARAINFLUENZA VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY VIRUS; REVIEW; RISK ASSESSMENT; TUBERCULOSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; VIRAL RESPIRATORY TRACT INFECTION; VIRAL UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS PNEUMONIA; VIRUS STRAIN;

CROSS INFECTION; HOSPITALS; HUMANS; INFLUENZA, HUMAN; NEOPLASMS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 66149106328     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70069-5     Document Type: Review

References (93)

1. Robinson G.V., Tegtmeier B.R., and Zaia J.A. Brief report: nosocomial infection rates in a cancer treatment center. Infect Control 5 (1984) 289-294
2. Rotstein C., Cummings K.M., Nicolaou A.L., et al. Nosocomial infection rates at an oncology center. Infect Control 9 (1988) 13-19
3. Simon A., Ammann R.A., Bode U., et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8 (2008) 70
4. Carlisle P.S., Gucalp R., and Wiernik P.H. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 14 (1993) 320-324
5. Dettenkofer M., Ebner W., Bertz H., et al. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation. Bone Marrow Transplant 31 (2003) 795-801
6. Dettenkofer M., Wenzler-Rottele S., Babikir R., et al. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 40 (2005) 926-931
7. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
8. Siegel J.D., Jackson M., and Chiarello L. Management of multi drug-resistant organisms in healthcare settings: 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf (accessed Jan 1, 2009).
9. Gerding D.N., Muto C.A., and Owens R.C. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 46 suppl 1 (2008) 43-49
10. Erard V., Chien J.W., Kim H.W., et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis 193 (2006) 1619-1625
11. Chemaly R.F., Ghosh S., Bodey G.P., et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 85 (2006) 278-287
12. Englund J.A., Boeckh M., Kuypers J., et al. Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients. Ann Intern Med 144 (2006) 344-349
13. Schenk T., Strahm B., Kontny U., et al. Disseminated bocavirus infection after stem cell transplant. Emerg Infect Dis 13 (2007) 1425-1427
14. Gutman J.A., Peck A.J., Kuypers J., and Boeckh M. Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases. Bone Marrow Transplant 40 (2007) 809-811
15. Harrington R.D., Hooton T.M., Hackman R.C., et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 165 (1992) 987-993
16. Englund J.A., Sullivan C.J., Jordan M.C., et al. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 109 (1988) 203-208
17. Martin M.A., Bock M.J., Pfaller M.A., and Wenzel R.P. Respiratory syncytial virus infections in adult bone marrow transplant recipients. Lancet 1 (1988) 1396-1397
18. Whimbey E., Couch R.B., Englund J.A., et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukaemia. Clin Infect Dis 21 (1995) 376-379
19. Small T.N., Casson A., Malak S.F., et al. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Bone Marrow Transplant 29 (2002) 321-327
20. Ghosh S., Champlin R.E., Ueno N.T., et al. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant 28 (2001) 271-275
21. Khanna N., Widmer A.F., Decker M., et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 46 (2008) 402-412
22. Torres H.A., Aguilera E.A., Mattiuzzi G.N., et al. Characteristics and outcome of respiratory syncytial virus infection in patients with leukaemia. Haematologica 92 (2007) 1216-1223
23. Boeckh M., Berrey M.M., Bowden R.A., et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 184 (2001) 350-354
24. Boeckh M., Englund J., Li Y., et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 44 (2007) 245-249
25. Adams R.H. Preemptive treatment of pediatric bone marrow transplant patients with asymptomatic respiratory syncytial virus infection with aerosolized ribavirin. Biol Blood Marrow Transplant 7 suppl (2001) 16-18
26. Sullivan K.M., Dykewicz C.A., Longworth D.L., et al. Preventing opportunistic infections after hematopoietic stem cell transplantation. Hematology Am Soc Hematol Educ Program (2001) 392-421
27. Peck A.J., Corey L., and Boeckh M. Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clin Infect Dis 39 (2004) 673-680
28. Product information: Virazole. http://www.valeant.com/fileRepository/products/PI/Virazole_Inhalation%20Solution%206gm_PI_Apr02.pdf (accessed Aug 1, 2008).
29. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 112 (2003) 1442-1446
30. Tablan O.C., Anderson L.J., Besser R., et al. Guidelines for preventing health-care associated pneumonia, 2003. MMWR Recomm Rep 53 (2004) 1-36
31. Plaskett T, Stiles J, Eagan J, et al. Isolation of immunocompromised patients with community respiratory viruses. Infectious Diseases Society of America; Chicago, IL, USA; Oct 24-27, 2002.
32. Weinstock D.M., Eagan J., Malak S.A., et al. Control of influenza A on a bone marrow transplant unit. Infect Control Hosp Epidemiol 21 (2000) 730-732
33. Machado C.M., Boas L.S., Mendes A.V., et al. Use of oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 34 (2004) 111-114
34. Vu D., Peck A.J., Nichols W.G., et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. Clin Infect Dis 45 (2007) 187-193
35. Hatakeyama S., Sugaya N., Ito M., et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297 (2007) 1435-1442
36. Baz M., Abed Y., McDonald J., and Boivin G. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 43 (2006) 1555-1561
37. Fiore A.E., Shay D.K., Haber P., et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56 (2007) 1-54
38. Klimov A.I., Rocha E., Hayden F.G., et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 172 (1995) 1352-1355
39. Kamboj M., and Sepkowitz K.A. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient. Infect Control Hosp Epidemiol 28 (2007) 702-707
40. Cortez K.J., Erdman D.D., Peret T.C., et al. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 184 (2001) 1093-1097
41. Hohenthal U., Nikoskelainen J., Vainionpaa R., et al. Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant 27 (2001) 295-300
42. Nichols W.G., Erdman D.D., Han A., et al. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant 10 (2004) 58-64
43. Lewis V.A., Champlin R., Englund J., et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 23 (1996) 1033-1037
44. Marcolini J.A., Malik S., Suki D., et al. Respiratory disease due to parainfluenza virus in adult leukaemia patients. Eur J Clin Microbiol Infect Dis 22 (2003) 79-84
45. Wendt C.H., Weisdorf D.J., Jordan M.C., et al. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 326 (1992) 921-926
46. Whimbey E., Vartivarian S.E., Champlin R.E., et al. Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 12 (1993) 699-701
47. Nichols W.G., Corey L., Gooley T., Davis C., and Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98 (2001) 573-578
48. Kadeishvili KS. Clinical presentation of parainfluenza virus infection in cancer patients: implications for infection control. 17th Annual Scientific Meeting of the Society of Healthcare Epidemiology of America; Baltimore, MD, USA; April 14-17, 2007.
49. Martino R., Porras R.P., Rabella N., et al. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 11 (2005) 781-796
50. Debiaggi M., Canducci F., Sampaolo M., et al. Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients. J Infect Dis 194 (2006) 474-478
51. Percivalle E., Sarasini A., Visai L., Revello M.G., and Gerna G. Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies. J Clin Microbiol 43 (2005) 3443-3446
52. Kamboj M., Gerbin M., Huang C.K., et al. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect 57 (2008) 464-471
53. Weinstock D.M., Boeckh M., Boulad F., et al. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues. Infect Control Hosp Epidemiol 25 (2004) 603-608
54. Weinstock D.M., Boeckh M., and Sepkowitz K.A. Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 12 (2006) 1096-1097
55. Geiser C.F., Bishop Y., Myers M., Jaffe N., and Yankee R. Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin. Cancer 35 (1975) 1027-1030
56. Zaia J.A., Levin M.J., Preblud S.R., et al. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis 147 (1983) 737-743
57. Asano Y., Yoshikawa T., Suga S., et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92 (1993) 219-222
58. Paryani S.G., Arvin A.M., Koropchak C.M., et al. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. J Pediatr 105 (1984) 200-205
59. Leung T.F., Li C.K., Hung E.C., et al. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 72 (2004) 353-357
60. Schrauder A., Henke-Gendo C., Seidemann K., et al. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet 369 (2007) 1232
61. Lin Y.S., Stout J.E., Yu V.L., and Vidic R.D. Disinfection of water distribution systems for legionella. Semin Respir Infect 13 (1998) 147-159
62. Knirsch C.A., Jakob K., Schoonmaker D., et al. An outbreak of legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control. Am J Med 108 (2000) 290-295
63. Kamboj M., and Sepkowitz K.A. The risk of tuberculosis in patients with cancer. Clin Infect Dis 42 (2006) 1592-1595
64. Malone J.L., Ijaz K., Lambert L., et al. Investigation of healthcare-associated transmission of Mycobacterium tuberculosis among patients with malignancies at three hospitals and at a residential facility. Cancer 101 (2004) 2713-2721
65. Michele T.M., Cronin W.A., Graham N.M., et al. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope: identification by DNA fingerprinting. JAMA 278 (1997) 1093-1095
66. Larson J.L., Lambert L., Stricof R.L., et al. Potential nosocomial exposure to Mycobacterium tuberculosis from a bronchoscope. Infect Control Hosp Epidemiol 24 (2003) 825-830
67. Hoy J.F., Rolston K.V., Hopfer R.L., and Bodey G.P. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am J Med 83 (1987) 213-217
68. Phillips M.S., and von Reyn C.F. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis 33 (2001) 1363-1374
69. Oren I., Haddad N., Finkelstein R., and Rowe J.M. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 66 (2001) 257-262
70. Klimowski L.L., Rotstein C., and Cummings K.M. Incidence of nosocomial aspergillosis in patients with leukaemia over a twenty-year period. Infect Control Hosp Epidemiol 10 (1989) 299-305
71. Brunetti L., De Caro F., Boccia G., Cavallo P., and Capunzo M. Surveillance of nosocomial infections: a preliminary study on yeast carriage on hands of healthcare workers. J Prev Med Hyg 49 (2008) 63-68
72. D'Antonio D., Violante B., Mazzoni A., et al. A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies. J Clin Microbiol 36 (1998) 792-795
73. Barchiesi F., Caggiano G., Di Francesco L.F., et al. Outbreak of fungemia due to candida parapsilosis in a pediatric oncology unit. Diagn Microbiol Infect Dis 49 (2004) 269-271
74. Hachem R., Hanna H., Kontoyiannis D., Jiang Y., and Raad I. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112 (2008) 2493-2499
75. Thompson N.D., Perz J.F., Moorman A.C., and Holmberg S.D. Non-hospital healthcare-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med 150 (2009) 33-39
76. Widell A., Christensson B., Wiebe T., et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Intern Med 130 (1999) 130-134
77. Silini E., Locasciulli A., Santoleri L., et al. Hepatitis C virus infection in a hematology ward: evidence for nosocomial transmission and impact on hematologic disease outcome. Haematologica 87 (2002) 1200-1208
78. Rieske K., Domula M., Liebert U.G., et al. Clinical aspects and epidemiology of hepatitis C in immunosuppressed children with mostly oncologic diseases. Klin Padiatr 210 (1998) 274-278
79. de Oliveira A.M., White K.L., Leschinsky D.P., et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 142 (2005) 898-902
80. Knoll A., Helmig M., Peters O., and Jilg W. Hepatitis C virus transmission in a pediatric oncology ward: analysis of an outbreak and review of the literature. Lab Invest 81 (2001) 251-262
81. Januszkiewicz-Lewandowska D., Wysocki J., Rembowska J., et al. Transmission of HCV infection among long-term hospitalized onco-haematological patients. J Hosp Infect 53 (2003) 120-123
82. Dumpis U., Kovalova Z., Jansons J., et al. An outbreak of HBV and HCV infection in a paediatric oncology ward: epidemiological investigations and prevention of further spread. J Med Virol 69 (2003) 331-338
83. Dibenedetto S.P., Ragusa R., Sciacca A., et al. Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia. Eur J Pediatr 153 (1994) 271-275
84. Allander T., Gruber A., Naghavi M., et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345 (1995) 603-607
85. Sepkowitz K.A. Risk to cancer patients from nosocomial hepatitis C virus. Infect Control Hosp Epidemiol 25 (2004) 599-602
86. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
87. Wands J.R., Walker J.A., Davis T.T., et al. Hepatitis B in an oncology unit. N Engl J Med 291 (1974) 1371-1375
88. Fisker N., Carlsen N.L., Kolmos H.J., et al. Identifying a hepatitis B outbreak by molecular surveillance: a case study. BMJ 332 (2006) 343-345
89. Lok A.S., and McMahon B.J. Chronic hepatitis B. Hepatology 45 (2007) 507-539
90. Hanna H., Benjamin R., Chatzinikolaou I., et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 22 (2004) 3163-3171
91. Rupp M.E., Lisco S.J., Lipsett P.A., et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 143 (2005) 570-580
92. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171 (2004) 466-472
93. Bobak D., Arfons L.M., Creger R.J., and Lazarus H.M. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?. Bone Marrow Transplant 42 (2008) 705-713